- Home
- XBP vs IGC Comparison
XBP vs IGC Comparison
Compare XBP & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XBP | IGC |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | 10200 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 27.7M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | XBP | IGC |
|---|---|---|
| Price | $3.63 | $0.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $5.25 |
| AVG Volume (30 Days) | 25.6K | ★ 323.5K |
| Earning Date | 05-15-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.09 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,271,000.00 |
| Revenue This Year | $2.59 | N/A |
| Revenue Next Year | $5.75 | $13.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.41 | $0.24 |
| 52 Week High | $8.55 | $0.50 |
Technical Indicators
Market Signals| Indicator | XBP | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 72.92 | 40.77 |
| Support Level | $3.31 | $0.25 |
| Resistance Level | $4.80 | $0.31 |
| Average True Range (ATR) | 0.36 | 0.01 |
| MACD | 0.11 | -0.00 |
| Stochastic Oscillator | 89.21 | 13.52 |
Price Performance
Historical ComparisonAbout XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.